InVivo Therapeutics Holdings Corp. (NVIV) Fell -5.69% or -0.47 To Price $7.79 On Friday


InVivo Therapeutics Holdings Corp. (NVIV) fell -5.69% or -0.47 to $7.79. It is near 151943 shares traded, which is 103.24% compare to the average total volume 147181. The market cap of NVIV is $12.19 million. The year to date change is -63.69%. The 52 week price range is from $6.25 to $96.25. Price of NVIV have changed 5.36% during last week. It have changed -32.61% over last month, -35.87% over last 3 months, -75.53% over last 6 months and -90.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVIV is 11.97. It is 53.66% above current price. The 200-day Moving Averages for NVIV is 25.46. It is 226.83% above current price. The 52-week High is 96.25. It is 1135.56% from the current price. The 52-week Low is 6.25. It is -19.77% from current price.

There are some statistics of NVIV. It is has market cap $12.19 million. The share outstanding is 1.56 million. The average volume is 147181. It has 65.10M cash and 3.20M in debt. The percent of top 15 Institution holding is 0.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVIV is -124.01%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVIV is -99.56%.


Tags:

Share this post